OraSure Technologies ROE 2012-2025 | OSUR
Current and historical return on equity (ROE) values for OraSure Technologies (OSUR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OraSure Technologies ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.06B | $0.36B | -15.75% |
| 2025-06-30 | $-0.05B | $0.38B | -12.90% |
| 2025-03-31 | $-0.03B | $0.40B | -7.96% |
| 2024-12-31 | $-0.02B | $0.41B | -4.98% |
| 2024-09-30 | $0.01B | $0.43B | 2.34% |
| 2024-06-30 | $0.03B | $0.43B | 6.16% |
| 2024-03-31 | $0.02B | $0.43B | 5.31% |
| 2023-12-31 | $0.05B | $0.43B | 13.05% |
| 2023-09-30 | $0.05B | $0.41B | 12.59% |
| 2023-06-30 | $0.04B | $0.39B | 11.78% |
| 2023-03-31 | $0.03B | $0.39B | 8.31% |
| 2022-12-31 | $-0.02B | $0.36B | -4.81% |
| 2022-09-30 | $-0.04B | $0.34B | -12.01% |
| 2022-06-30 | $-0.06B | $0.34B | -17.32% |
| 2022-03-31 | $-0.05B | $0.37B | -11.96% |
| 2021-12-31 | $-0.02B | $0.38B | -5.58% |
| 2021-09-30 | $-0.01B | $0.39B | -2.51% |
| 2021-06-30 | $0.01B | $0.41B | 1.50% |
| 2021-03-31 | $0.00B | $0.40B | -0.76% |
| 2020-12-31 | $-0.01B | $0.40B | -3.84% |
| 2020-09-30 | $-0.01B | $0.39B | -4.10% |
| 2020-06-30 | $0.00B | $0.38B | -0.63% |
| 2020-03-31 | $0.01B | $0.29B | 4.05% |
| 2019-12-31 | $0.02B | $0.31B | 5.44% |
| 2019-09-30 | $0.02B | $0.30B | 8.33% |
| 2019-06-30 | $0.02B | $0.29B | 6.73% |
| 2019-03-31 | $0.02B | $0.28B | 6.87% |
| 2018-12-31 | $0.02B | $0.28B | 7.38% |
| 2018-09-30 | $0.02B | $0.28B | 6.42% |
| 2018-06-30 | $0.02B | $0.27B | 5.81% |
| 2018-03-31 | $0.02B | $0.26B | 6.43% |
| 2017-12-31 | $0.03B | $0.26B | 12.68% |
| 2017-09-30 | $0.03B | $0.25B | 13.73% |
| 2017-06-30 | $0.03B | $0.23B | 15.00% |
| 2017-03-31 | $0.03B | $0.21B | 15.68% |
| 2016-12-31 | $0.02B | $0.19B | 10.95% |
| 2016-09-30 | $0.02B | $0.18B | 10.19% |
| 2016-06-30 | $0.01B | $0.17B | 7.37% |
| 2016-03-31 | $0.01B | $0.16B | 6.23% |
| 2015-12-31 | $0.01B | $0.16B | 5.04% |
| 2015-09-30 | $0.00B | $0.16B | 0.00% |
| 2015-06-30 | $0.00B | $0.16B | 0.00% |
| 2015-03-31 | $0.00B | $0.16B | 0.63% |
| 2014-12-31 | $-0.01B | $0.16B | -3.15% |
| 2014-09-30 | $0.00B | $0.16B | 2.51% |
| 2014-06-30 | $0.00B | $0.16B | 0.63% |
| 2014-03-31 | $-0.01B | $0.16B | -4.47% |
| 2013-12-31 | $-0.01B | $0.16B | -6.97% |
| 2013-09-30 | $-0.02B | $0.16B | -14.38% |
| 2013-06-30 | $-0.02B | $0.16B | -13.94% |
| 2013-03-31 | $-0.02B | $0.16B | -14.57% |
| 2012-12-31 | $-0.02B | $0.17B | -11.03% |
| 2012-09-30 | $-0.01B | $0.18B | -7.59% |
| 2012-06-30 | $-0.01B | $0.10B | -11.14% |
| 2012-03-31 | $-0.01B | $0.10B | -9.07% |
| 2011-12-31 | $-0.01B | $0.10B | -9.05% |
| 2011-09-30 | $-0.01B | $0.10B | -9.98% |
| 2011-06-30 | $-0.01B | $0.10B | -5.88% |
| 2011-03-31 | $-0.01B | $0.10B | -4.89% |
| 2010-12-31 | $0.00B | $0.10B | -3.90% |
| 2010-09-30 | $-0.01B | $0.10B | -5.84% |
| 2010-06-30 | $0.00B | $0.10B | -3.86% |
| 2010-03-31 | $-0.01B | $0.10B | -7.71% |
| 2009-12-31 | $-0.01B | $0.10B | -7.62% |
| 2009-09-30 | $-0.03B | $0.11B | -32.08% |
| 2009-06-30 | $-0.04B | $0.10B | -33.33% |
| 2009-03-31 | $-0.04B | $0.11B | -28.28% |
| 2008-12-31 | $-0.03B | $0.11B | -23.35% |
| 2008-09-30 | $0.00B | $0.14B | -1.42% |
| 2008-06-30 | $0.00B | $0.14B | 0.00% |
| 2008-03-31 | $0.00B | $0.14B | 2.16% |
| 2007-12-31 | $0.00B | $0.14B | 1.47% |
| 2007-09-30 | $0.00B | $0.14B | 2.25% |
| 2007-06-30 | $0.01B | $0.14B | 3.82% |
| 2007-03-31 | $0.01B | $0.13B | 3.90% |
| 2006-12-31 | $0.01B | $0.13B | 3.98% |
| 2006-09-30 | $0.03B | $0.13B | 20.37% |
| 2006-06-30 | $0.03B | $0.12B | 23.89% |
| 2006-03-31 | $0.03B | $0.12B | 26.41% |
| 2005-12-31 | $0.03B | $0.12B | 30.60% |
| 2005-09-30 | $0.01B | $0.09B | 8.67% |
| 2005-06-30 | $0.00B | $0.08B | 3.87% |
| 2005-03-31 | $0.00B | $0.08B | 2.63% |
| 2004-12-31 | $0.00B | $0.08B | 0.00% |
| 2004-09-30 | $0.00B | $0.08B | 0.00% |
| 2004-06-30 | $0.00B | $0.08B | 0.00% |
| 2004-03-31 | $0.00B | $0.07B | -1.98% |
| 2003-12-31 | $0.00B | $0.07B | -5.19% |
| 2003-09-30 | $0.00B | $0.03B | -7.55% |
| 2003-06-30 | $0.00B | $0.03B | -7.84% |
| 2003-03-31 | $0.00B | $0.03B | -8.00% |
| 2002-12-31 | $0.00B | $0.03B | -12.12% |
| 2002-09-30 | $-0.01B | $0.02B | -20.00% |
| 2002-06-30 | $-0.01B | $0.02B | -19.23% |
| 2002-03-31 | $0.00B | $0.03B | -15.09% |
| 2001-12-31 | $0.00B | $0.03B | -11.32% |
| 2001-09-30 | $-0.01B | $0.03B | -19.05% |
| 2001-06-30 | $-0.01B | $0.03B | -48.60% |
| 2001-03-31 | $-0.01B | $0.03B | -51.49% |
| 2000-12-31 | $-0.01B | $0.03B | -56.52% |
| 2000-09-30 | $-0.01B | $0.03B | -54.05% |
| 2000-06-30 | $0.00B | $0.02B | -22.64% |
| 2000-03-31 | $0.00B | $0.02B | -38.10% |
| 1999-12-31 | $0.00B | $0.01B | -45.71% |
| 1999-09-30 | $0.00B | $0.01B | -45.71% |
| 1999-06-30 | $0.00B | $0.01B | -46.15% |
| 1999-03-31 | $0.00B | $0.01B | -47.06% |
| 1998-12-31 | $0.00B | $0.01B | -100.00% |
| 1998-09-30 | $0.00B | -53.33% | |
| 1998-06-30 | $-0.01B | -106.67% | |
| 1998-03-31 | $-0.01B | -81.63% | |
| 1997-12-31 | $-0.02B | $0.02B | -122.58% |
| 1997-09-30 | $-0.02B | $0.02B | -109.09% |
| 1997-06-30 | $-0.01B | $0.02B | -65.82% |
| 1997-03-31 | $-0.01B | $0.01B | -31.46% |
| 1996-12-31 | $0.00B | $0.02B | 4.12% |
| 1996-09-30 | $0.00B | $0.03B | 0.00% |
| 1996-06-30 | $0.00B | $0.03B | -17.20% |
| 1996-03-31 | $-0.01B | $0.02B | -52.75% |
| 1995-12-31 | $-0.02B | $0.02B | -62.50% |
| 1995-09-30 | $-0.02B | $0.02B | -78.26% |
| 1995-06-30 | $-0.02B | $0.03B | -81.82% |
| 1995-03-31 | $-0.02B | $0.03B | -87.80% |
| 1994-12-31 | $-0.02B | $0.02B | -100.00% |
| 1994-09-30 | $-0.02B | $0.02B | -106.67% |
| 1994-06-30 | $-0.02B | $0.02B | -120.00% |
| 1994-03-31 | $-0.01B | $0.01B | -155.56% |
| 1993-12-31 | $-0.02B | $0.01B | -176.47% |
| 1993-09-30 | $-0.02B | $0.01B | -162.16% |
| 1993-06-30 | $-0.01B | $0.01B | -136.84% |
| 1993-03-31 | $-0.01B | $0.01B | -114.29% |
| 1992-12-31 | $-0.01B | $0.01B | -81.82% |
| 1992-09-30 | $-0.01B | $0.01B | -71.11% |
| 1992-06-30 | $-0.01B | $0.01B | -64.00% |
| 1992-03-31 | $-0.01B | $0.01B | -58.33% |
| 1991-12-31 | $-0.01B | $0.01B | -52.17% |
| 1991-09-30 | $-0.01B | $0.01B | -48.78% |
| 1991-06-30 | $0.00B | $0.01B | -48.48% |
| 1991-03-31 | $0.00B | $0.01B | -53.33% |
| 1990-12-31 | $0.00B | $0.01B | -59.26% |
| 1990-09-30 | $0.00B | $0.01B | -61.54% |
| 1990-06-30 | $0.00B | $0.01B | -44.44% |
| 1990-03-31 | $0.00B | $0.01B | -42.86% |
| 1989-12-31 | $0.00B | $0.01B | -50.00% |
| 1989-09-30 | $0.00B | $0.01B | -60.00% |
| 1989-06-30 | $0.00B | $0.01B | -70.59% |
| 1989-03-31 | $0.00B | $0.00B | -92.31% |
| 1988-12-31 | $0.00B | $0.00B | -80.00% |
| 1988-09-30 | $0.00B | $0.00B | -47.06% |
| 1988-06-30 | $0.00B | $0.00B | -44.44% |
| 1988-03-31 | $0.00B | $0.01B | -23.53% |
| 1987-12-31 | $0.00B | $0.01B | 0.00% |
| 1987-09-30 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.197B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $214.803B | 24.76 |
| EssilorLuxottica (ESLOY) | France | $151.023B | 0.00 |
| Stryker (SYK) | United States | $138.625B | 27.52 |
| Boston Scientific (BSX) | United States | $133.464B | 30.52 |
| Medtronic (MDT) | Ireland | $126.919B | 17.58 |
| Medline (MDLN) | United States | $56.109B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.167B | 0.00 |
| Agilent Technologies (A) | United States | $41.059B | 25.95 |
| ResMed (RMD) | United States | $38.047B | 26.33 |
| GE HealthCare Technologies (GEHC) | United States | $37.585B | 17.98 |
| Koninklijke Philips (PHG) | Netherlands | $29.051B | 18.98 |
| Terumo (TRUMY) | Japan | $20.817B | 23.43 |
| Insulet (PODD) | United States | $20.154B | 62.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.589B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.974B | 0.00 |
| Baxter (BAX) | United States | $10.471B | 8.45 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.688B | 31.24 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.338B | 13.22 |
| BillionToOne (BLLN) | United States | $4.335B | 0.00 |
| Envista Holdings (NVST) | United States | $4.060B | 23.29 |
| ICU Medical (ICUI) | United States | $3.829B | 24.31 |
| Haemonetics (HAE) | United States | $3.464B | 15.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.155B | 14.39 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.403B | 15.45 |
| Perrigo (PRGO) | Ireland | $2.088B | 5.23 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| Neogen (NEOG) | United States | $2.058B | 45.05 |
| LeMaitre Vascular (LMAT) | United States | $1.962B | 39.50 |
| Curaleaf Holdings (CURLF) | Canada | $1.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.715B | 75.18 |
| Phibro Animal Health (PAHC) | United States | $1.624B | 16.22 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.459B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Kestra Medical Technologies (KMTS) | United States | $1.341B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 349.57 |
| Capricor Therapeutics (CAPR) | United States | $1.099B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.090B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.944B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 10.04 |
| Omeros (OMER) | United States | $0.866B | 0.00 |
| Valneva SE (VALN) | France | $0.865B | 0.00 |
| CeriBell (CBLL) | United States | $0.847B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.75 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.452B | 77.00 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.371B | 0.00 |
| Evolus (EOLS) | United States | $0.324B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 22.85 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.212B | 0.00 |
| Accendra Health (ACH) | United States | $0.196B | 1.96 |
| Utah Medical Products (UTMD) | United States | $0.193B | 17.02 |
| Vireo Growth (VREOF) | United States | $0.193B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Exagen (XGN) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.78 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Nephros (NEPH) | United States | $0.047B | 33.69 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.86 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |